SEC Form 4 · accession 0001651844-15-000006

NYMOX PHARMACEUTICAL CORP · NYMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 30, 2015

Accepted (ET)

Dec 4, 2015 · 6:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001018735

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 30, 2015	P	12,552	$3.28	A	2,280,102	D
Common Stock	Nov 30, 2015	P	848	$3.29	A	2,280,950	D
Common Stock	Dec 1, 2015	P	9,500	$3.36	A	2,290,450	D
Common Stock	Dec 1, 2015	P	7,100	$3.35	A	2,297,550	D
Common Stock	Dec 1, 2015	P	10,000	$3.31	A	2,307,550	D
Common Stock	Dec 1, 2015	P	10,000	$3.33	A	2,317,550	D
Common Stock	Dec 2, 2015	P	590	$3.40	A	2,318,140	D
Common Stock	Dec 2, 2015	P	10,000	$3.63	A	2,328,140	D
Common Stock	Dec 3, 2015	P	10,000	$3.46	A	2,338,140	D
Common Stock	Dec 3, 2015	P	9,410	$3.61	A	2,347,550	D
Common Stock	Dec 4, 2015	P	10,000	$3.55	A	2,357,550	D
Common Stock	Dec 4, 2015	P	10,000	$3.53	A	2,367,550	D
Common Stock	Dec 4, 2015	P	10,000	$3.49	A	2,377,550	D
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust

No Table II lines on this filing.